申请人:Université de Strasbourg
公开号:EP3257863A1
公开(公告)日:2017-12-20
The present invention relates to metabolically stable and non-immunogen analogs completely hydrosoluble at physiological pH, and their use for the prevention or treatment of diseases mediated by G-protein coupled receptor (GPCR), in particular (Central Nervous System) CNS and cardiovascular diseases or disorders.
本发明涉及在生理 pH 值下完全水溶的代谢稳定的非免疫原类似物,以及它们在预防或治疗由 G 蛋白偶联受体(GPCR)介导的疾病,特别是(中枢神经系统)中枢神经系统和心血管疾病或紊乱方面的用途。